Seer Inc (NAS:SEER)
$ 2.26 0.07 (3.2%) Market Cap: 133.26 Mil Enterprise Value: -91.96 Mil PE Ratio: 0 PB Ratio: 0.39 GF Score: 54/100

Seer Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2023 / 04:15PM GMT
Release Date Price: $2.58 (+0.39%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Hello, everyone. Good morning. I'm Tejas Savant and I cover the Life Science Tools and Diagnostics sector here at Morgan Stanley. Before we begin, important disclosures. Please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, do reach out to your sales rep.

So it's my pleasure this morning to host here. And on behalf of the company, we have Omid Farokhzad CEO; and David Horn, CFO. So thanks, gents, for spending the next 30 minutes with me. Omid, I want to start at a high level, right? So despite some of the near-term headwinds, which we get to later in the chat, I want to talk to you about sort of what's gone right over the last 12 months for SEER? At an industry level, the excitement around multiomic in general and proteomic specifically is tappable. What are you most proud of in terms of what you've accomplished since IPO?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot